← Back
$TARS All transactions

Tarsus Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$200K

Shares

2,989

Price

$67

Filed

Mar 24

Insider

Name

Neervannan Seshadri

Title

Chief Operating Officer

CIK

0001827584

Roles

Officer

Transaction Details

Transaction Date

2026-03-20

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

82,791

Footnotes

The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025. | This holding balance is related to the Reporting Person's daughter who shares the Reporting Person's household. The Reporting Person disclaims beneficial ownership of the securities held by his daughter, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purposes.

Filing Info

Accession No.

0001827584-26-000011

Form Type

4

Issuer CIK

0001819790

Neervannan Seshadri's History

Date Ticker Type Value
2026-03-20 TARS $200K
2025-12-16 TARS G $0
2025-12-16 TARS G $0

Other Insiders at TARS (90d)

No other insider activity at this issuer in the last 90 days.